| Novartis Pharma Schweiz AG - Lamisil 125 mg, Tabletten |
| 51306 | | 01 | | Lamisil 125 mg | | Tabletten | | D01BA02 | | Terbinafine | | 27.08.1991 | | |
|
| Composition |
| terbinafinum 125 mg ut terbinafini hydrochloridum, carboxymethylamylum natricum A corresp. natrium max. 1 mg, lactosum monohydricum 21.0 mg, cellulosum microcristallinum hypromellosum, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Terbinafine | 125 mg |
| | BAG: Active Agent | Dose |
|---|
| Terbinafine | 125 mg |
| | | | Inactive agents | Dose |
|---|
| Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum Hypromellosum | | | Lactose Monohydrate | 21 mg | | Magnesii Stearas | | | Pro Compresso | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 031 | 14 Tablet(s) | 21.83 | 39.75 | B | SL | Yes |
|
